Please provide your email address to receive an email when new articles are posted on . Use of multiparametric MRI led to significantly higher diagnosis rates in all hospitals studied. Patients ...

Preoperative MRI, specifically 9-b-value DWI and T1-mapping, helps predict if a patient will develop stage 3 CKD after partial or radical nephrectomy for kidney cancer. Preoperative multiparametric ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...

A deep learning model was as effective as radiologists in detecting clinically significant prostate cancer on multiparametric MRI, a retrospective study suggested. In an internal test set of 400 ...

Association between artificial intelligence–derived tumor volume and oncologic outcomes in localized prostate cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary Cancers ...

Enhancing PSA-based screening with multiparametric magnetic resonance imaging (MRI) improves detection of prostate cancer among men with germline mutations while reducing unnecessary biopsies. For men ...

Researchers from the Hong Kong University of Science and Technology (HKUST) have developed Mixture of Modality Experts (MOME), a large artificial intelligence (AI) model for non-invasive breast cancer ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according to a study published in ...

Multiparametric qMRI effectively differentiates between DMD and BMD in ambulatory children, especially under 10 years old with mild symptoms. Fat fraction (FF) is the preferred qMRI biomarker for ...

SWOG 0941: A phase II study of sorafenib and erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.

Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...